3.7.0.1 html 94 233 1 false 35 0 false 7 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.vandapharmaceuticals.com/taxonomy/role/StatementOfFinancialPositionClassified CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 104 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.vandapharmaceuticals.com/taxonomy/role/StatementOfIncomeAlternative CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 106 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.vandapharmaceuticals.com/taxonomy/role/StatementOfOtherComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 5 false false R6.htm 107 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.vandapharmaceuticals.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 108 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.vandapharmaceuticals.com/taxonomy/role/StatementOfCashFlowsIndirect CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 109 - Disclosure - Business Organization and Presentation Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock Business Organization and Presentation Notes 8 false false R9.htm 110 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Summary of Significant Accounting Policies Notes 9 false false R10.htm 111 - Disclosure - Earnings per Share Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Earnings per Share Notes 10 false false R11.htm 112 - Disclosure - Marketable Securities Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock Marketable Securities Notes 11 false false R12.htm 113 - Disclosure - Fair Value Measurements Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value Measurements Notes 12 false false R13.htm 114 - Disclosure - Inventory Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock Inventory Notes 13 false false R14.htm 115 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsPrepaidExpensesDepositsAndOtherCurrentAssetsTextBlock Prepaid Expenses and Other Current Assets Notes 14 false false R15.htm 116 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock Accounts Payable and Accrued Liabilities Notes 15 false false R16.htm 117 - Disclosure - Intangible Assets Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlock Intangible Assets Notes 16 false false R17.htm 118 - Disclosure - Income Taxes Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes Notes 17 false false R18.htm 119 - Disclosure - Commitments and Contingencies Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies Notes 18 false false R19.htm 120 - Disclosure - Stock-Based Compensation Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock-Based Compensation Notes 19 false false R20.htm 121 - Disclosure - Legal Matters Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsLegalMattersAndContingenciesTextBlock Legal Matters Notes 20 false false R21.htm 122 - Disclosure - Business Organization and Presentation (Policies) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlockPolicies Business Organization and Presentation (Policies) Policies http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock 21 false false R22.htm 123 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables Summary of Significant Accounting Policies (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock 22 false false R23.htm 124 - Disclosure - Earnings per Share (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Earnings per Share (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock 23 false false R24.htm 125 - Disclosure - Marketable Securities (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlockTables Marketable Securities (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock 24 false false R25.htm 126 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value Measurements (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock 25 false false R26.htm 127 - Disclosure - Inventory (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables Inventory (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock 26 false false R27.htm 128 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsPrepaidExpensesDepositsAndOtherCurrentAssetsTextBlockTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsPrepaidExpensesDepositsAndOtherCurrentAssetsTextBlock 27 false false R28.htm 129 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables Accounts Payable and Accrued Liabilities (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock 28 false false R29.htm 130 - Disclosure - Intangible Assets (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlockTables Intangible Assets (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlock 29 false false R30.htm 131 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables Commitments and Contingencies (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock 30 false false R31.htm 132 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock-Based Compensation (Tables) Tables http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock 31 false false R32.htm 133 - Disclosure - Business Organization and Presentation - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureBusinessOrganizationAndPresentationAdditionalInformation Business Organization and Presentation - Additional Information (Detail) Details 32 false false R33.htm 134 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation Summary of Significant Accounting Policies - Additional Information (Detail) Details 33 false false R34.htm 135 - Disclosure - Net Sales by Product (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureNetSalesByProduct Net Sales by Product (Detail) Details 34 false false R35.htm 136 - Disclosure - Basic and Diluted Net Loss Per Share of Common Stock (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureBasicAndDilutedNetLossPerShareOfCommonStock Basic and Diluted Net Loss Per Share of Common Stock (Detail) Details 35 false false R36.htm 137 - Disclosure - Summary of Available-For-Sale Marketable Securities (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureSummaryOfAvailableForSaleMarketableSecurities Summary of Available-For-Sale Marketable Securities (Detail) Details 36 false false R37.htm 138 - Disclosure - Assets Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureAssetsMeasuredAtFairValueOnRecurringBasis Assets Measured at Fair Value on Recurring Basis (Detail) Details 37 false false R38.htm 139 - Disclosure - Inventory (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureInventory Inventory (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables 38 false false R39.htm 140 - Disclosure - Summary of Prepaid Expenses and Other Current Assets (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureSummaryOfPrepaidExpensesAndOtherCurrentAssets Summary of Prepaid Expenses and Other Current Assets (Detail) Details 39 false false R40.htm 141 - Disclosure - Summary of Accounts Payable and Accrued Liabilities (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureSummaryOfAccountsPayableAndAccruedLiabilities Summary of Accounts Payable and Accrued Liabilities (Detail) Details 40 false false R41.htm 142 - Disclosure - Summary of Intangible Assets (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureSummaryOfIntangibleAssets Summary of Intangible Assets (Detail) Details 41 false false R42.htm 143 - Disclosure - Intangible Assets (Textual 2 - HETLIOZ) - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureIntangibleAssetsTextual2HETLIOZAdditionalInformation Intangible Assets (Textual 2 - HETLIOZ) - Additional Information (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlockTables 42 false false R43.htm 144 - Disclosure - Intangible Assets (Textual 3 - Fanapt) - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureIntangibleAssetsTextual3FanaptAdditionalInformation Intangible Assets (Textual 3 - Fanapt) - Additional Information (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlockTables 43 false false R44.htm 145 - Disclosure - Intangible Assets - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformation Intangible Assets - Additional Information (Detail) Details 44 false false R45.htm 146 - Disclosure - Summary of Future Intangible Asset Amortization (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureSummaryOfFutureIntangibleAssetAmortization Summary of Future Intangible Asset Amortization (Detail) Details 45 false false R46.htm 147 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation Commitments and Contingencies - Additional Information (Detail) Details 46 false false R47.htm 148 - Disclosure - Summary of Minimum Annual Future Payments Under Operating Leases and Subleases for Office Space (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureSummaryOfMinimumAnnualFuturePaymentsUnderOperatingLeasesAndSubleasesForOfficeSpace Summary of Minimum Annual Future Payments Under Operating Leases and Subleases for Office Space (Detail) Details 47 false false R48.htm 149 - Disclosure - Commitments and Contingencies (Textual 2 - HETLIOZ) - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureCommitmentsAndContingenciesTextual2HETLIOZAdditionalInformation Commitments and Contingencies (Textual 2 - HETLIOZ) - Additional Information (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables 48 false false R49.htm 150 - Disclosure - Commitments and Contingencies (Textual 3 - Fanapt) - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureCommitmentsAndContingenciesTextual3FanaptAdditionalInformation Commitments and Contingencies (Textual 3 - Fanapt) - Additional Information (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables 49 false false R50.htm 151 - Disclosure - Commitments and Contingencies (Textual 4 - Tradipitant) - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureCommitmentsAndContingenciesTextual4TradipitantAdditionalInformation Commitments and Contingencies (Textual 4 - Tradipitant) - Additional Information (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables 50 false false R51.htm 152 - Disclosure - Commitments and Contingencies (Textual 5 - CFTR Activators and Inhibitors - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureCommitmentsAndContingenciesTextual5CFTRActivatorsAndInhibitorsAdditionalInformation Commitments and Contingencies (Textual 5 - CFTR Activators and Inhibitors - Additional Information (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables 51 false false R52.htm 153 - Disclosure - Stock-Based Compensation (Textual 1 - Stock-Based Compensation) - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureStockBasedCompensationTextual1StockBasedCompensationAdditionalInformation Stock-Based Compensation (Textual 1 - Stock-Based Compensation) - Additional Information (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables 52 false false R53.htm 154 - Disclosure - Stock-Based Compensation (Textual 2 Stock Option) - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureStockBasedCompensationTextual2StockOptionAdditionalInformation Stock-Based Compensation (Textual 2 Stock Option) - Additional Information (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables 53 false false R54.htm 155 - Disclosure - Summary of Option Activity for 2006 Plan and the 2016 Plan (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureSummaryOfOptionActivityFor2006PlanAndThe2016Plan Summary of Option Activity for 2006 Plan and the 2016 Plan (Detail) Details 54 false false R55.htm 156 - Disclosure - Stock-Based Compensation (Textual 3 RSU) - Additional Information (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureStockBasedCompensationTextual3RSUAdditionalInformation Stock-Based Compensation (Textual 3 RSU) - Additional Information (Detail) Details http://www.vandapharmaceuticals.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables 55 false false R56.htm 157 - Disclosure - Summary of RSU Activity Plan (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureSummaryOfRSUActivityPlan Summary of RSU Activity Plan (Detail) Details 56 false false R57.htm 158 - Disclosure - Total Stock-Based Compensation Expense (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureTotalStockBasedCompensationExpense Total Stock-Based Compensation Expense (Detail) Details 57 false false R58.htm 159 - Disclosure - Black-Scholes-Merton Option Pricing Model for Stock Options Granted (Detail) Sheet http://www.vandapharmaceuticals.com/taxonomy/role/DisclosureBlackScholesMertonOptionPricingModelForStockOptionsGranted Black-Scholes-Merton Option Pricing Model for Stock Options Granted (Detail) Details 58 false false All Reports Book All Reports vnda-20170630.xml vnda-20170630.xsd vnda-20170630_cal.xml vnda-20170630_def.xml vnda-20170630_lab.xml vnda-20170630_pre.xml true true